CORD-19:04c300fc145b27f210fe05c52a93de14920c17bc / 30710-30895 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T192","span":{"begin":0,"end":185},"obj":"Sentence"}],"text":"This analysis concentrated on BLV/ VSV pseudotype formation inhibition, polykaryotosis inhibition (cell/cell fusion following infection), and complement fixation (Bruck et al., 1982b) ."}

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T192","span":{"begin":0,"end":185},"obj":"Sentence"},{"id":"T31504","span":{"begin":0,"end":185},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"This analysis concentrated on BLV/ VSV pseudotype formation inhibition, polykaryotosis inhibition (cell/cell fusion following infection), and complement fixation (Bruck et al., 1982b) ."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T73","span":{"begin":126,"end":135},"obj":"Disease"}],"attributes":[{"id":"A73","pred":"mondo_id","subj":"T73","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"This analysis concentrated on BLV/ VSV pseudotype formation inhibition, polykaryotosis inhibition (cell/cell fusion following infection), and complement fixation (Bruck et al., 1982b) ."}